(Q43563104)
Statements
Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy (English)
Penna A
Ogg GS
Pilli M
Cavallo C
Cavalli A
Urbani S
Boehme R
Panebianco R
Fiaccadori F